Amol Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 7.50 M
- Paid Up Capital ₹ 6.65 M
- Company Age 29 Year, 10 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 43.13 Cr
- Satisfied Charges ₹ 36.74 Cr
- Revenue Growth 10.53%
- Profit Growth -18.23%
- Ebitda -25.20%
- Net Worth 15.60%
- Total Assets 6.50%
About Amol Pharmaceuticals
Amol Pharmaceuticals Private Limited (APPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 12 February 1996 and has a history of 29 years. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 7.50 M and a paid-up capital of Rs 6.65 M.
The company currently has active open charges totaling ₹43.13 Cr. The company has closed loans amounting to ₹36.74 Cr, as per Ministry of Corporate Affairs (MCA) records.
Ashok Luhadia and Sandeep Sapra serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24230MH1996PTC097178
- Company No.
097178
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Feb 1996
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
What products or services does Amol Pharmaceuticals Private Limited offer?
Amol Pharmaceuticals Private Limited offers a wide range of products and services, including TB, Tumor & Cancer Drugs, Anti Cancer Medicines, Anti Cancer Injection, Common Disease Medicines, Pharmaceutical Capsules, Injectable Products, Brain & Nervous System Drugs, Psychotherapeutic Agents, Homeopathic Medicines & Remedies, Homeopathic Drugs.
Who are the key members and board of directors at Amol Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sandeep Sapra  | Managing Director | 01-Mar-1996 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashok Luhadia  | Director | 12-Feb-1996 | Current |
Financial Performance of Amol Pharmaceuticals.
Amol Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 10.53% increase. The company also saw a substantial fall in profitability, with a 18.23% decrease in profit. The company's net worth Soared by an impressive increase of 15.6%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Amol Pharmaceuticals?
In 2023, Amol Pharmaceuticals had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Amol Properties Private LimitedAshok Luhadia and Sandeep Sapra are mutual person
- Appl Pharmalab Private Limited
Sandeep Sapra is a mutual person
Charges (Loans)
₹431.30 M
₹367.39 M
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 43.13 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Dec 2020 | Hdfc Bank Limited | ₹43.13 Cr | Open |
| 22 Jul 2020 | State Bank Of India | ₹4.13 Cr | Satisfied |
| 07 Apr 2020 | State Bank Of India | ₹2.40 Cr | Satisfied |
| 10 Feb 1997 | State Bank Of India | ₹29.46 Cr | Satisfied |
| 04 Feb 1997 | State Bank Of Bikaner And Jaipur | ₹0.90 M | Satisfied |
How Many Employees Work at Amol Pharmaceuticals?
Amol Pharmaceuticals has a workforce of 316 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Amol Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Amol Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
